Addus HomeCare Co. (NASDAQ:ADUS) Position Boosted by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. boosted its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 5.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 108,314 shares of the company's stock after acquiring an additional 5,719 shares during the quarter. Assenagon Asset Management S.A. owned 0.60% of Addus HomeCare worth $14,409,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quest Partners LLC acquired a new position in shares of Addus HomeCare during the second quarter worth about $31,000. Innealta Capital LLC acquired a new position in shares of Addus HomeCare during the second quarter worth about $44,000. EntryPoint Capital LLC acquired a new position in shares of Addus HomeCare during the first quarter worth about $44,000. Finally, Sandia Investment Management LP acquired a new position in shares of Addus HomeCare during the second quarter worth about $58,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Insider Activity at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now owns 3,866 shares in the company, valued at $502,695.98. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 over the last three months. 4.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have commented on ADUS. StockNews.com cut Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research note on Sunday, July 7th. Macquarie restated an "outperform" rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Friday, October 11th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $141.00 target price on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Oppenheimer lifted their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Monday, September 23rd. Finally, TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a research report on Thursday, August 8th. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $131.38.

Addus HomeCare Trading Down 0.9 %

Addus HomeCare stock traded down $1.14 during midday trading on Friday, hitting $127.96. The stock had a trading volume of 106,849 shares, compared to its average volume of 130,955. The stock has a market cap of $2.32 billion, a P/E ratio of 31.75, a P/E/G ratio of 2.33 and a beta of 1.04. Addus HomeCare Co. has a 12 month low of $78.35 and a 12 month high of $136.12. The business has a fifty day moving average price of $130.54 and a 200 day moving average price of $119.40.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million during the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. Addus HomeCare's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.94 earnings per share. On average, equities analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.